Express

US Pharmaceutical Company Artelo Announces Launch of Solana Reserve Asset Strategy

Summary: According to reports, pharmaceutical company Artelo Biosciences (NASDAQ: ARTL) announced the completion of a $9.475 million private placement financing to launch a digital asset reserve strategy centered around Solana (SOL), becoming the first publicly traded pharmaceutical company to include SOL in its reserve assets. The private placement includes the issuance of common stock (or pre-funded ...

According to reports, pharmaceutical company Artelo Biosciences (NASDAQ: ARTL) announced the completion of a $9.475 million private placement financing to launch a digital asset reserve strategy centered around Solana (SOL), becoming the first publicly traded pharmaceutical company to include SOL in its reserve assets. The private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.

Last Update:

Tags:
Link: US Pharmaceutical Company Artelo Announces Launch of Solana Reserve Asset Strategy [Copy]

Last: Verb Technology Plans $558 Million Private Placement to Launch TON Reserve Strategy

Next: Ether Machine acquires an additional 10,600 ETH, total holdings exceed 345,000 ETH

BTC Weekly Outlook: The Oversold Bounce—A Bottom or a Shorting Opportunity? 3 days ago

The Making of a Political Darling: Is Chainlink’s Government Deal a Victory for Tech or... 7 days ago

Google Steps Into Blockchain: A New Front in the “Ledger Wars” 9 days ago

Bitcoin Weekly Analysis: Is a Bear Market on the Horizon? 11 days ago

AI Fraud Is Breaking the Internet’s Trust Economy. Can Compliance Tech Keep Up? 14 days ago